Adams Business Associates, (ABA) provides practical business support for High Technology Businesses.

Our specialised focus is on Life Sciences, Bio-Research, Diagnostics, Healthcare and Biotechnology. ABA provides business development, stategic marketing, B2B services and reports based on sound management and technical experience.

Together we identify effective marketing decisions directed to improving profitability and the long term success of your business with Independent assessments and strategies controlled by Financial Analysis and Health Technology Assessment.

We use our detailed experience for each stage of your business or product development from: Design through to Development and to Launch.


Latest Items

Life Science Research Global Library: Full EMEA Coverage & Status at March 2018.

All eight (8) regional ABA Global Library reports were made available during 2017 with 2016 as the market base line with business and commercial developments during the year covered by Appendices. During 2017 major full new analyses were prepared that detailed the actual outcomes for 2016, plus Individual country budgets for 2017 and those proposed for 2018. For all these reports new further sections have been added that detail the events and market quantification for 2017 with projections to 2022.

These reports are for:

  • ABA 348.3A - Middle East, Arabia & North Africa.
  • ABA 350.3A Vol. 1 Eastern Majors of China, India & Japan with Pakistan, Hong Kong, Bangladesh & Sri Lanka.
  • ABA 355.3A Vol. 2. 11 countries in the Pacific region including those of Australia & New Zealand.
  • ABA 360.3A - Central & Eastern Europe.
  • ABA 370.3A - Latin & South America.
  • ABA 374.3A - Western Europe.
  • ABA 375.3 - North America: USA and Canada.

The Contents Lists and Abstracts for these EMEA reports and all Global Library Reports can be seen on the Latest Reports page of the web site. More information on the EMEA region reports can be found on the Articles Page.

Read article...

Diagnostics Report Series 2017 Updates for all three analyses.

  • Point-of-Care Tests - Personalised Medicine & POCT, ABA 310.
  • Molecular Diagnostics - Technologies, Products & Services for MDx, ABA 298.
  • Cell Based Assays - Technologies, Applications, Products & Services, ABA 413.

The three reports in this series have now been updated with all activities and market dynamics to the end of 2017 and early 2018. This has allowed the latest market figures to be included and the reports are among the first reports in the Diagnostics sector to have 2017 market quantification as the base line for market data. These are global market reports and detail the technologies used together with the range of applications for clinical diagnostics, research and other applications.

Full details of Contents Lists and Abstracts are available for each sector Link to Contents List & Abstract on Business Development page.

Read article...